ENDO 2012 provides the opportunity to reach more than 7,500 thought leaders in endocrinology. Create a presence at ENDO—increase your exposure and improve your return on investment through pre-meeting messaging, convention center and hotel-based advertising, on-site events, and trainee activities.

ENDO 2012 Opportunities for Support Brochure (download PDF)

ENDO 2012 will bring together the scientists and clinicians who can impact your business. This is great news, especially considering that exhibitor leads were up by 28% at ENDO 2011. Of all ENDO 2011 attendees:

• 72% have an MD degree
• 75% attend ONLY ENDO and no other medical meeting
• 89% see patients, write prescriptions and order diagnostic tests.
  

Reach the world’s most influential endocrinologists; become an ENDO 2012 exhibitor or for more information about exhibiting and meeting-related advertising at ENDO 2012 contact Darrin Scherago at 201-653-4777, ext. 20.

The Endocrine Society will acknowledge ENDO 2012 supporters in the following ways*:

• Advance and Highlights Programs (Circ: 38,500)
• Flyer in Attendee Meeting Bag (Circ: 8,000)
• Meeting & Exhibit Guide (Circ: 8,000)
• Citation in ENDO ads running in Society Journals (Circ: 100,000)
• Citation in the April & June issues of Endocrine News (Circ: 44,000)
• Signs outside event rooms and on the Expo floor (Circ: 8,000)
• Slides and announcements at Plenary & Session Rooms (Circ: 32,000)
• Listing of The Endocrine Society’s Web site (Circ: 1.2 million)
• Listings in the April & May issues of The Endocrine Society Update online newsletter (Circ: 44,000)
• Listing in The Endocrine Society’s ENDO Attendee online newsletter (Circ: 5,300)
  

*If support confirmed by April 15, 2012

Industry Supporters’ ENDO 2011 Return on Investment

Thank you to our industry supporters for helping make ENDO 2011 our most successful and highest-attended annual meeting to date! We are pleased to provide supporters with information detailing the high return on investment from ENDO and ENDOExpo 2011.

The Society appreciates the generosity of all companies that supported ENDO 2011 as well as the 2011 Leadership Donors.

**Please note:
External guidelines and policies (such as the ACCME’s Standards for Commercial Support, the OIG’s Compliance Program Guidance for Pharmaceutical Manufacturers, PhRMA’s new Code on Interaction with Healthcare Professionals, AdvaMed’s Code for Ethics for Interactions with Healthcare Professionals, etc.) may impact availability or access to the sponsorship opportunities currently listed. Please contact Teresa Favero, Director of Development, at tfavero@endo-society.org or 301-941-0229 for more information.